Literature DB >> 26077616

Cerebral Blood Flow Responses to Autonomic Dysreflexia in Humans with Spinal Cord Injury.

Aaron A Phillips1,2,3,4,5, Philip N Ainslie6, Darren E R Warburton1,2,3,4,5, Andrei V Krassioukov3,4,5.   

Abstract

Autonomic dysreflexia (AD) is a life-threatening episode of transient hypertension affecting up to 90% of those with high-level spinal cord injury (SCI), and can lead to cerebral hemorrhage. Due to the nature of this medical emergency, cerebral blood flow (CBF) has not been recorded during AD. Beat-by-beat blood pressure (BP) and CBF velocity of the middle cerebral artery were measured during spontaneous AD episodes in four motor complete cervical SCI patients. Mean arterial BP increased during AD (66 ± 11 vs. 83 ± 10 mm Hg; p = 0.004), whereas CBF (76 ± 4 vs. 74 ± 4 cm · sec(-1)) and end-tidal partial pressure of carbon dioxide (PETCO2) (35 ± 1 vs. 34 ± 3 mm Hg) were maintained. These preliminary data indicate that the brain may effectively buffer moderate episodes of AD.

Entities:  

Keywords:  autonomic dysfunction; cerebrovascular; paraplegia; tetraplegia

Mesh:

Year:  2016        PMID: 26077616     DOI: 10.1089/neu.2015.3871

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  3 in total

Review 1.  Autonomic dysreflexia after spinal cord injury: Systemic pathophysiology and methods of management.

Authors:  Khalid C Eldahan; Alexander G Rabchevsky
Journal:  Auton Neurosci       Date:  2017-05-08       Impact factor: 3.145

2.  A comparison of static and dynamic cerebral autoregulation during mild whole-body cold stress in individuals with and without cervical spinal cord injury: a pilot study.

Authors:  Jan W van der Scheer; Yoshi-Ichiro Kamijo; Christof A Leicht; Philip J Millar; Manabu Shibasaki; Victoria L Goosey-Tolfrey; Fumihiro Tajima
Journal:  Spinal Cord       Date:  2018-01-12       Impact factor: 2.772

3.  Autonomic dysreflexia associated with cervical spinal cord gliofibroma: case report.

Authors:  Hiroyuki Mizuno; Fumiaki Honda; Hayato Ikota; Yuhei Yoshimoto
Journal:  BMC Neurol       Date:  2021-06-29       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.